Ultrasensitive Detection Of Prostate Specific Antigen Research Articles

A self-powered photoelectrochemical aptasensor based on target response and Ag-CdIn2S4 photosensitive material for ultrasensitive detection of prostate-specific antigen

In this study, Ag-CdIn2S4 was selected as a photosensitive material and combined with the zeolite imidazole frame-90 encapsulated methylene blue (ZIF-90@MB) to establish a controlled release system. On that basis, a self-powered photoelectrochemical (PEC) aptasensor was constructed based on target responses to realize the highly sensitive detection of prostate-specific antigen (PSA). The self-powered sensing method was employed to effectively avoid interference from other oxidizing/reducing substances in the system and improve the accuracy of the detection method. The band gap of CdIn2S4 was adjusted by Ag doping, and the visible light absorption capacity and photoelectric conversion efficiency of the material were improved by the local surface plasmon resonance (LSPR) effect of metal Ag. The ZIF-90 porous material was used as a carrier, the MB photosensitizer as a signal molecule was loaded in the ZIF-90 pore channel. The PSA aptamer (PApt) was attached to the ZIF-90@MB surface to form a simple biological gate. In the presence of the PSA, the recognition interaction between PApt and PSA made the biological gate open, then many MB molecules were released from ZIF-90 and enhanced the photocurrent signal. Under the optimal experimental conditions, the linear range of the sensor was 0.005 ∼ 50 ng mL−1, and the detection limit was 2.35 pg mL−1. The accurate determination of PSA in human serum was achieved, which provided a novel sensing strategy for the early diagnosis of clinical biomarkers.

Boosting Electrochemiluminescence Performance of a Dual-Active Site Iron Single-Atom Catalyst-Based Luminol-Dissolved Oxygen System via Plasmon-Induced Hot Holes.

Due to the commonly low content of biomarkers in diseases, increasing the sensitivity of electrochemiluminescence (ECL) systems is of great significance for in vitro ECL diagnosis and biodetection. Although dissolved O2 (DO) has recently been considered superior to H2O2 as a coreactant in the most widely used luminol ECL systems owing to its improved stability and less biotoxicity, it still has unsatisfactory ECL performance because of its ultralow reactivity. In this study, an effective plasmonic luminol-DO ECL system has been developed by complexing luminol-capped Ag nanoparticles (AgNPs) with plasma-treated Fe single-atom catalysts (Fe-SACs) embedded in graphitic carbon nitride (g-CN) (pFe-g-CN). Under optimal conditions, the performance of the resulting ECL system could be markedly increased up to 1300-fold compared to the traditional luminol-DO system. Further investigations revealed that duple binding sites of pFe-g-CN and plasmonically induced hot holes that disseminated from AgNPs to g-CN surfaces lead to facilitate significantly the luminous reaction process of the system. The proposed luminol-DO ECL system was further employed for the stable and ultrasensitive detection of prostate-specific antigen in a wide linear range of 1.0 fg/mL to 1 μg/mL, with a pretty low limit of detection of 0.183 fg/mL.

Ultrasensitive detection of prostate-specific antigen using a SERS-based magnetic immunosensor

Concentrations of disease biomarkers and their changes are crucial for the diagnosis and monitoring of diseases, so detecting and capturing small changes in biomarkers is especially important. This study demonstrates a surface-enhanced Raman scattering (SERS)-active magnetic immunosensor using a signal amplification strategy for the ultrasensitive detection of prostate-specific antigen (PSA). The sensor consists of a biotin-modified aptamer (B-Apt) and a PSA antibody (Ab) labeled on magnetic beads (MBs), which can immobilize and anchor the target PSA when it is present. After sequential addition of streptavidin and a signal probe, the generated streptavidin-biotin complex reacts to form a three-dimensional network, thereby increasing the number of signal molecules to achieve signal amplification, with the detection limit of 0.87 pg/mL. In addition, this method was also performed to detect PSA in human serum samples. It is believed that this method provides a more sensitive tool for detecting PSA or other biomarkers in clinical samples.

Ultrasensitive detection of PSA in human serum using Label-Free electrochemical biosensor with magnetically induced Self-Assembly based on α-Fe2O3/Fe3O4@Au nanocomposites

To achieve the goals of early diagnosis, screening, and precision medicine for prostate cancer, this research designed a label-free electrochemical biosensor by combining magnetic probes (PSAA/α-Fe2O3/Fe3O4@Au) with magnetically induced self-assembly (MISA) technology to explore the application of prostate-specific antigen (PSA) in precise detection. Magnetic α-Fe2O3/Fe3O4 nanoparticles (NPs) were constructed using a hydrothermal-calcination reduction method. Subsequently, α-Fe2O3/Fe3O4@Au nanocomposites were prepared by reducing HAuCl4 with NaBH4 at a low temperature. The self-assembly method was adopted in two steps: firstly, the sulfhydryl-modified PSA aptamer is immobilized onto the material surface using Au–S bonds; secondly, the magnetic NPs and magnetic glassy carbon electrode (MGCE) undergo self-assembly. The biosensor showed good linear response in the range of 100 fg/mL to 100 ng/mL, with a detection limit of 0.78 pg/mL (S/N = 3) under optimal conditions. Repeatability, stability, selectivity, reproducibility, and the capability to analyze real samples were also investigated. With its cost-effectiveness, operational simplicity, and speed of analysis, the biosensing system platform holds great potential as a valuable tool in clinical PSA detection for point-of-care testing (POCT).

Single-molecule microfluidic assay for prostate-specific antigen based on magnetic beads and upconversion nanoparticles.

Early-stage diagnosis of prostatic carcinoma is essential for successful treatment and, thus, significant prognosis improvement. In laboratory practice, the standard non-invasive diagnostic approach is the immunochemical detection of the associated biomarker, prostate-specific antigen (PSA). Ultrasensitive detection of PSA is essential for both diagnostic and recurrence monitoring purposes. To achieve exceptional sensitivity, we have developed a microfluidic device with a flow-through cell for single-molecule analysis using photon-upconversion nanoparticles (UCNPs) as a detection label. For this purpose, magnetic microparticles (MBs) were first optimized for the capture and preconcentration of PSA and then used to implement a bead-based upconversion-linked immunoassay (ULISA) in the microfluidic device. The digital readout based on counting single nanoparticle-labeled PSA molecules on MBs enabled a detection limit of 1.04 pg mL-1 (36 fM) in 50% fetal bovine serum, which is an 11-fold improvement over the respective analog MB-based ULISA. The microfluidic technique conferred several other advantages, such as easy implementation and the potential for achieving high-throughput analysis. Finally, it was proven that the microfluidic setup is suitable for clinical sample analysis, showing a good correlation with a reference electrochemiluminescence assay (recovery rates between 97% and 105%).

Sandwich-type electrochemical immunosensor based on nitrogen-doped porous carbon and nanoporous trimetallic nanozyme (PdAgCu) for determination of prostate specific antigen.

Asandwich-type electrochemical immunosensor was designed for the ultrasensitive detection of prostate-specific antigen (PSA), using Au nanoparticles (Au NPs) modified nitrogen-doped porous carbon (NPC) as sensor platform and trimetallic PdAgCu mesoporous nanospheres (PdAgCu MNSs) as enzyme-mimicking labels. NPC was prepared by a facile one-step pyrolysis strategy of biomimetic phylloid zeolite imidazole framework (ZIF-L) nanosheets. Through this strategy, the graphitization of the microcrystalline structure enhanced the electrical conductivity, while its enlarged specific surface area and abundant pore volume can enrich H2O2 to improve the catalytic efficiency. Moreover, Au NPs were used to modify NPC without cross-linking agents to further optimize electron transport while capturing primary antibodies, improving stability and sensitivity of theimmunosensor. PdAgCu MNSs with uniform size, cylindrical open mesoporous channels, and continuous crystal frame structure were self-assembling synthesized by electrostatic adsorption and ascorbic acid (AA) co-reduction with amphiphilic dioctadecyldimethylammonium chloride (DODAC) as surfactant-cum-micelle, whose unique structure maximizes the use of polyatoms to expose catalytic sites, exhibiting good biocompatibility and electrocatalytic ability. Under the optimal conditions, the immunosensor showed superior sensitivity, a wide dynamic detection range (10fgmL-1 ~ 100ngmL-1) and a low limit of detection (LOD, 3.29fgmL-1). This work provides a convenient strategy for the clinical detection of PSA.

An electrochemiluminescence immunosensor based on ABEI-GO-AgNPs as a double-amplified luminophore for the ultra-sensitive detection of prostate-specific antigen

A sandwich electrochemiluminescence (ECL) immunosensor based on an N-(4-aminobutyl)-N-ethylisoluminol-graphene oxide-Ag nanoparticle (ABEI-GO-AgNPs) complex and cysteine silver nanowires (AgCysNWs) was prepared to detect prostate-specific antigen (PSA). Our results showed that an ECL signal probe, ABEI-GO-AgNPs, with an ultrahigh specific surface area, favorable catalytic properties, and electrical conductivity was prepared by a one-step synthesis method. ABEI-GO-AgNPs with good biocompatibility immobilized secondary antibody (Ab2) via AgN bonds. Furthermore, AgCysNWs containing many –COOH groups were prepared and used to enrich primary antibody (Ab1), which could be used as an affinity probe for the selective capture of PSA. Lastly, through layer-by-layer assembly, we established an ECL immunosensing platform for the sensitive detection of PSA. Under the optimized conditions, the designed ECL immunosensor showed promising sensitivity and selectivity for the detection of PSA in the linear range of 5.5 × 10−7–5.5 ng/mL, with a detection limit of 1.2 × 10−7 ng/mL. The constructed ECL sensing platform possessed good specificity, reproducibility, and stability and could detect PSA in actual human serum samples.

Optical fiber peptide-sensor for ultrasensitive detection of prostate specific antigen

We develop the first optical fiber-based peptisensor with chemiluminescent detection, and apply it for ultrasensitive detection of prostate-specific antigen (PSA), an important biomarker for early diagnosis of prostate disease. Optical fiber is used not only as the carrier of the biological recognition elements (the specific biotinylated peptides, bio-KQLKSSHC), but also for the excellent light conduction for chemiluminescence signal output. The peptisensor is easily fabricated and gold nanoparticles (AuNPs) modified with horseradish peroxidase (HRP) are employed as the signal label for chemiluminescent detection. By combining the streptavidin-biotin system and the large surface area of AuNPs, both the peptide loading amount and the chemiluminescence signal are enhanced, thus the response of the peptisensor is greatly improved with a wide linear range of 0.80 pg/mL −100 ng/mL (2.42 ×10−9-3.03 ×10−4 nmol) and a low limit-of-detection of 0.30 pg/mL (9.09 ×10−10 nmol). The HRP@AuNPs@peptide optical fiber peptisensor exhibiting good reproducibility and selectivity for PSA assays. Our study indicates that the optical fiber-based peptisensors would be of value for sensitive detection of biomarkers with advantages of low-cost, easy operation and possibly for miniaturization, thus would they have great potential application in vitro diagnosis.

Plasmon-Boosted Fe, Co Dual Single-Atom Catalysts for Ultrasensitive Luminol-Dissolved O2 Electrochemiluminescence Detection of Prostate-Specific Antigen

Improving the sensitivity of electrochemiluminescence (ECL) systems is highly desired for in vitro ECL diagnosis and bio-detections due to the often-low content of biomarkers in diseases. And dissolved O2 (DO) as a co-reactant is considered superior to H2O2 in the most commonly used luminol ECL systems due to better stability and low biotoxicity, but it still suffers from low ECL performance due to the low reactivity of DO. In this study, an efficient luminol-DO ECL system was developed through the complexing of Fe, Co dual single-atom catalysts (D-SACs) supported by N-doped graphene with the luminol-capped Ag nanoparticles (AgNPs). Benefiting from the electronic interaction between Fe and Co metal sites in the relevant D-SACs and plasmon enhancement of AgNPs, the performance of the corresponding ECL system could be significantly boosted up to ≈677-fold under optimal testing conditions, comparable to the classic luminol-O2 system. Furthermore, the developed luminol-DO ECL system was successfully applied for the stable ultrasensitive detection of prostate-specific antigen (PSA) in a wide linear range of 1 fg/mL to 1 μg/mL, with a low limit of detection (0.98 fg/mL).

Ultrasensitive detection of prostate-specific antigen using glucose-encapsulated nanoliposomes anti-PSA polyclonal antibody as detection nanobioprobes

In this work, the preparation of glucose encapsulating nanoliposomes was achieved using two different lipid formulations, labelled as F1 and F2. Both formulations contained phosphatidylcholine (PC), oleylamido-4-butanoic acid (OABA) and in addition, F1 had cholesterol (CHO) while F2 contained cholesteroyl hemisussinate (CHEMS). These formulations were studied for their pH sensitivity and controlled release of encapsulated glucose for indirect detection of prostate-specific antigen (PSA) using sandwich immunoassay. As a signal generator, encapsulated glucose in nanoliposomes was quantified directly using the personal glucose meter (PGM) and colorimetrically using peroxidase property of horseradish peroxidase (HRP) enzyme and Pd|PdO as nanozymes. Controlled release of the encapsulated glucose was achieved using the pH effect or Triton-X 100 as a surfactant to destabilize the liposomal structure. The F2 formulation showed maximum controlled release at acidic phosphate buffer saline (PBS, pH 5.0). The concentration of encapsulated glucose was found to be high in F2 formulation and these were applied for the indirect detection of PSA. The limit of detection (LOD) values for PSA were found to be 53 fg mL−1, 64 fg mL−1 and 10 fg mL−1 when HRP, Pd|PdO and PGM were respectively used. The detection signal was linear over a wide concentration range for PSA including the clinical range of 4–10 ng mL−1. The HRP system showed low LOD value when compared with Pd|PdO nanozymes. PGM system gave lowest LOD values owing to the sensitivity of the system towards glucose. Pd|PdO nanozyme system showed good stability over a wide temperature up to 80 °C. PGM system required less reaction time (2 min), low reagents and results were readily generated in digital format.

Light Scattering and Luminophore Enrichment-Enhanced Electrochemiluminescence by a 2D Porous Ru@SiO2 Nanoparticle Membrane and Its Application in Ultrasensitive Detection of Prostate-Specific Antigen.

Electrochemiluminescence (ECL) by virtue of its controllability and versatility has emerged as a significant tool in bioassay, but how to integrate it with other (nano)materials and further break the limit of sensitivity for ultrasensitive detection still possess tremendous potential. Herein, a close-packed Ru@SiO2 NP nanomembrane that serves as an enhanced substrate and luminophore enricher simultaneously was constructed by the liquid-liquid interface self-assembly method and applied for ECL-enhanced bioassay. The developed ECL electrode obtained ∼600-fold enhancement on ECL intensity compared with the bare ITO electrode and ∼21-fold enhancement compared with the SiO2 NP nanomembrane electrode due to the dramatic light scattering of the 2D SiO2 NPs and the enrichment of Ru(bpy)32+ molecules on the surface of the Ru@SiO2 NP nanomembrane electrode. Based on the fascinating Ru@SiO2 NP nanomembrane platform, we further constructed a label-free immunosensor for the detection of prostate-specific antigen (PSA). The as-fabricated Ru@SiO2-nanomembrane ECL immunosensor exhibited good stability and performed ultrasensitive detection with an utmost low detection limit of 0.169 fg·mL-1 (signal/noise = 3). Our work puts forward an effective solution benefiting for further improving ECL performance for ultrasensitive bioassays.

A novel affinity peptide–antibody sandwich electrochemical biosensor for PSA based on the signal amplification of MnO2-functionalized covalent organic framework

This work describes a novel affinity peptide–antibody sandwich electrochemical strategy for the ultrasensitive detection of prostate-specific antigen (PSA). Herein, polydopamine-coated boron-doped carbon nitride (Au@PDA@BCN) was synthesized and used as a sensing platform to anchor gold nanoparticles and immobilize primary antibody. Meanwhile, AuPt metallic nanoparticle and manganese dioxide (MnO2)-functionalized covalent organic frameworks (AuPt@MnO2@COF) was facilely synthesized to serve as a nanocatalyst and ordered nanopore for the enrichment and amplification of signal molecules (methylene blue, MB). PSA affinity peptide was bound to AuPt@MnO2@COF to form Pep/MB/AuPt@MnO2@COF nanocomposites (probe). The peptide–PSA–antibody sandwich biosensor was constructed, and the redox signal of MB was measured with the existence of PSA. The fabricated sensor exhibited a linear response (0.00005–10 ng mL−1) with a low detection limit of 16.7 fg mL−1 under the optimum condition. Additionally, the sensor showed an excellent selectivity, ideal repeatability, and good stability for PSA detection in real samples. Furthermore, the porous structure of COF can enrich more MB molecules and increase the sensitivity of the biosensor. This study provides an efficient and ultrasensitive strategy for PSA detection and broadens the use of organic/inorganic porous nanocomposite in biosensing.

Ultrasensitive ratiometric photoelectrochemical immunoassay for prostate specific antigen based on nanoscale heterojunction

A new photoelectrochemical (PEC) immunosensor is fabricated for the ultrasensitive detection of prostate-specific antigen (PSA). Nanoscale poly(indole-5-carboxylic acid) (P5ICA)/WO3 p-n type heterojunction is firstly used as the photoactive material with good photoelectric activity and chemical stability. The energy level matching effect between P5ICA and WO3 is conducive to the generation of stronger photocurrent signals. The sensitization effect of this heterojunction can also increase the absorption range of visible light and improve the utilization of light. This ratiometric device includes detection section (DS) and reference section (RS), which are equipped on a single FTO electrode. DS incubates with different concentrations of PSA, and RS incubates with a constant concentration of PSA. Thus, the ultrasensitive ratiometric detection of PSA is achieved by the ratio value of photocurrents (DS/RS), reducing the impact of external factors on detection results effectively. This sensor exhibits a dynamic working range between 0.0005−50 ng mL−1 with a limit of detection (LOD) of 0.00012 ng mL−1 and a limit of quantification (LOQ) of 0.0004 ng mL−1. In addition, this sensor has high selectivity, good portability and acceptable detection accuracy in actual samples, which indicates potential applications for detection of disease-related biomarkers.

A DNA triangular prism-based fluorescent aptasensor for ultrasensitive detection of prostate-specific antigen

In this study, a fluorescent aptasensor is described for ultrasensitive detection of prostate-specific antigen (PSA) using DNA triangular prism as a platform for attachment of fluorophore (PicoGreen, PG), streptavidin magnetic beads (SMBs) and RecJf exonuclease as enhancers of fluorescence difference between presence and absence of target. Presence of PSA leads to the formation of the DNA origami. So, a strong fluorescence is observed following the addition of PG. while, the DNA triangular prism cannot be formed in the lack of target. Thus, a very weak fluorescence can be measured after addition of PG. The proposed biosensor indicated high selectivity, a broad linear range from 200 pg/mL to 300 ng/mL and a very low detection limit of 30 pg/mL for PSA. Applying the designed aptasensor, PSA was successfully detected in human serum samples. This work provides a new way for detection of biomarkers in clinical samples.

A surface-enhanced electrochemiluminescence sensor based on Au-SiO2 core-shell nanocomposites doped with Ru(bpy)32+ for the ultrasensitive detection of prostate-specific antigen in human serum.

This study reports a surface-enhanced electrochemiluminescence (SEECL) sensor for the ultrasensitive detection of prostate-specific antigen (PSA) in human serum. First, we prepared the Au-SiO2 core-shell nanocomposites doped with Ru(bpy)32+ (Au@SiO2-Ru) as the ECL signal generation and amplification element of the SEECL sensor. Ru(bpy)32+ could emit ECL under the excitation of an electrochemical reaction, and generate the local surface plasmon resonance (LSPR) electromagnetic field from the gold nanoparticle (AuNP) core. The produced LSPR then effectively enhanced the ECL signals. This sensing strategy was utilized for the detection of PSA, which can be absorbed on the electrode surface by the reaction between PSA and monoclonal antibodies. When polyclonal antibody-modified Au@SiO2-Ru was added, the PSA-double-antibody sandwich structure was formed on the electrode surface and thus, the Au@SiO2-Ru were quantitatively immobilized on the electrode surface. The results show that this kind of SEECL sensor has good selectivity toward PSA. Notably, the minimum detection concentration reached 7 × 10-7 ng mL-1 under the optimum experimental conditions, which is much better than most of the previously reported approaches for the detection of PSA in serum.

Colorimetric switchable linker-based bioassay for ultrasensitive detection of prostate-specific antigen as a cancer biomarker.

The use of colorimetric bioassays for protein detection is one of the most interesting diagnostic approaches, but their relatively poor detection limits have been a critical issue. In this study, we developed an efficient colorimetric bioassay based on switchable linkers (SLs) for the detection of prostate-specific antigen (PSA), which is one of the most widely used protein biomarkers for the diagnosis of prostate and breast cancers. SLs can cross-link gold nanoparticles (AuNPs) to generate large-scale aggregates and thereby induce precipitation to achieve visual signal amplification. In addition, when SLs are occupied by target proteins (referred to as 'switch-off'), highly sensitive detection is enabled. To maximize sensitivity, we adjusted the total surface area of AuNPs by controlling their concentration. As a result, PSA was detected at an ultralow concentration of 100 fg mL-1. This SL-based assay is shown to be simple, easy to handle and visualize, and highly sensitive. Therefore, in addition to PSA, the proposed SL-based assay could be used to detect other protein biomarkers.

Cosensitization Strategy with Cascade Energy Level Arrangement for Ultrasensitive Photoelectrochemical Protein Detection.

Here, a photoelectrochemical (PEC) biosensor was established by a cosensitization strategy with cascade energy level arrangement for ultrasensitive detection of prostate-specific antigen (PSA). The proposed cosensitization strategy was based on the well-matched energy level arrangement of four kinds of organic photoactive materials, in which poly{4,8-bis[5-(2-ethylhexyl)thiophen-2-yl]benzo[1,2- b:4,5- b']dithiophene-2,6-diyl- alt-3-fluoro-2-[(2-ethylhexyl)-carbonyl]thieno[3,4- b]thiophene-4,6-diyl} (PTB7-Th) was used as the photoactive material and perylenetetracarboxyl diimide (PDI), fullerene (nano-C60), and polyaniline (PANI) were employed as the sensitizers. The resulting PTB7-Th/PDI/nano-C60/PANI cascade cosensitization structure with narrow energy level gradient (<0.54 eV) could effectively improve electron transfer capability, obviously raise light energy utilization and significantly enhance photoelectric conversion efficiency, leading to dramatically enhanced photocurrent response. Using PSA as a target model, the proposed PEC biosensor exhibited high sensitivity and excellent stability with a wide detection range from 1 fg/mL to 0.1 ng/mL and a detection limit of 0.43 fg/mL. Moreover, the proposed PEC biosensor provides a cascade cosensitization strategy that could significantly improve PEC performances and open up a promising platform to establish high selectivity, stability, and ultrasensitive analytical techniques.

Double Photosystems-Based 'Z-Scheme' Photoelectrochemical Sensing Mode for Ultrasensitive Detection of Disease Biomarker Accompanying Three-Dimensional DNA Walker.

A new double photosystems-based 'Z-scheme' photoelectrochemical (PEC) sensing platform is designed for ultrasensitive detection of prostate-specific antigen (PSA) by coupling with a three-dimensional (3D) DNA walker. Two photosystems consist of CdS quantum dots (photosystem I; PS I) and BiVO4 photoactive materials (photosystem II; PS II), whereas gold nanoparticles (AuNPs) photodeposited on high-active {010} facets of BiVO4 are used as the electron mediators to promote electron transfer from conduction band of PS II to valence band of PS I. 3D DNA walker-based amplification strategy is carried out between hairpin DNA1 conjugated onto the AuNP, hairpin DNA2 labeled with CdS quantum dot (QD-H2), and DNA walker complementary with the PSA aptamer modified to a magnetic bead (Apt-MB). Upon addition of target, DNA walker strand is displaced from DNA walker/Apt-MB to open hairpin DNA1 on AuNP@BiVO4. In the presence of QD-H2, DNA walker induces the hybridization of DNA1 with DNA2 on the gold nanoparticles step by step, thereby resulting in the assembly of CdS QDs on the AuNP@BiVO4 to form Z-scheme double photosystems with strong photocurrent. Under optimum conditions, the Z-scheme PEC sensing system exhibits good photocurrent responses toward target PSA within the working range of 0.01-50 ng mL-1 at a low detection limit of 1.5 pg mL-1. Good reproducibility and accuracy are acquired for analysis of target PSA and human serum specimens relative to the commercial PSA ELISA kit. Importantly, our strategy provides a new horizon for photoelectrochemical in vitro diagnostics.

Sandwich-type electrochemical immunosensor for ultrasensitive detection of prostate-specific antigen using palladium-doped cuprous oxide nanoparticles

A new and facile sandwich-type electrochemical immunosensor is proposed for the ultrasensitive detection of prostate-specific antigen (PSA) based on Au nanoparticles (Au NPs) and palladium-doped cuprous oxide nanoparticles (Pd@Cu2O NPs).

Real-time prostate-specific antigen detection with prostate-specific antigen imprinted capacitive biosensors

Prostate specific antigen (PSA) is a valuable biomarker for early detection of prostate cancer, the third most common cancer in men. Ultrasensitive detection of PSA is crucial to screen the prostate cancer in an early stage and to detect the recurrence of the disease after treatment. In this report, microcontact-PSA imprinted (PSA-MIP) capacitive biosensor chip was developed for real-time, highly sensitive and selective detection of PSA. PSA-MIP electrodes were prepared in the presence of methacrylic acid (MAA) as the functional monomer and ethylene glycol dimethacrylate (EGDMA) as the cross-linker via UV polymerization. Immobilized Anti-PSA antibodies on electrodes (Anti-PSA) for capacitance measurements were also prepared to compare the detection performances of both methods. The electrodes were characterized by atomic force microscopy (AFM), scanning electron microscopy (SEM) and cyclic voltammetry (CV) and real-time PSA detection was performed with standard PSA solutions in the concentration range of 10 fg mL−1–100 ng mL−1. The detection limits were found as 8.0 × 10−5 ng mL−1 (16 × 10−17 M) and 6.0 × 10−4 ng mL−1 (12 × 10−16 M) for PSA-MIP and Anti-PSA electrodes, respectively. Selectivity studies were performed against HSA and IgG and selectivity coefficients were calculated. PSA detection was also carried out from diluted human serum samples and finally, reproducibility of the electrodes was tested. The results are promising and show that when the sensitivity of the capacitive system is combined with the selectivity and reproducibility of the microcontact-imprinting procedure, the resulting system might be used successfully for real-time detection of various analytes even in very low concentrations.